Tiziana Life Sciences Ltd. (NASDAQ: TLSA)
$0.81
N/A ( 0% ) 21.7K
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Market Data
Open
$0.81
Previous close
$0.81
Volume
21.7K
Market cap
$82.23M
Day range
$0.81 - $0.84
52 week range
$0.41 - $1.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Dec 19, 2023 |
6-k | Quarterly Reports | 3 | Dec 04, 2023 |
6-k | Quarterly Reports | 3 | Dec 01, 2023 |
6-k | Quarterly Reports | 3 | Nov 30, 2023 |
6-k | Quarterly Reports | 3 | Nov 01, 2023 |
6-k | Quarterly Reports | 3 | Oct 18, 2023 |
6-k | Quarterly Reports | 4 | Oct 16, 2023 |
6-k | Quarterly Reports | 4 | Oct 13, 2023 |
6-k | Quarterly Reports | 3 | Oct 11, 2023 |
6-k | Quarterly Reports | 3 | Sep 26, 2023 |